Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Michigan Medical Genetics Laboratories, |
RCV000113914 | SCV000267736 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2016-04-21 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000113914 | SCV000743246 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2014-10-09 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV002267813 | SCV002550259 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Breast Cancer Information Core |
RCV000113914 | SCV000147337 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | 2010-12-17 | no assertion criteria provided | clinical testing | |
Clinical Genetics Laboratory, |
RCV001689600 | SCV001906014 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001689600 | SCV001953824 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
BRCAlab, |
RCV000113914 | SCV004243926 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2020-03-02 | no assertion criteria provided | clinical testing |